Guillain-Barré syndrome in pregnancy

Czech version

Authors: Hledíková Andrea ¹; Hruban Lukáš ¹; Jura René ²; Sas Igor ³; Hrdý Ondřej ³; Janků Petr ¹
Authors‘ workplace: Gynekologicko-porodnická klinika LF MU a FN Brno ¹; Neurologická klinika LF MU a FN Brno ²; Klinika anesteziologie, resuscitace a intenzivní medicíny LF MU a FN Brno ³
Published in: Ceska Gynekol 2021; 86(3): 189-193
Category: Case Report
doi: https://doi.org/10.48095/cccg2021189

Overview

Objective: A case report of a 23-year-old pregnant woman diagnosed with Guillain-Barré syndrome in the 31st week of pregnancy.

Case report: We present a case study of a patient in the 31st week of pregnancy hospitalized at the University Hospital in Brno for expressed bulbar syndrome, neck muscle weakness, paresthesia of the arms and medical history of diarrhea in the previous week. During hospitalization, there was a rapid progression of symptoms and respiratory failure, requiring orotracheal intubation. The diagnosis of Guillain-Barré syndrome was determined and intravenous immunoglobulin therapy was initiated. The pregnancy was terminated in the 32nd week of gestation based on the maternal indication after a completed lung maturation of the fetus.

Conclusion: Guillain-Barré syndrome is a neurological disease that can rarely occur during pregnancy and puerperium. The syndrome presents a serious pregnancy complication with an uncertain prognosis and risk for both mother and fetus. If the syndrome is diagnosed in time and treated correctly, the prognosis is favorable despite the complicated course.

Keywords:

Guillain-Barre syndrome – respiratory failure in pregnancy – maternal morbidity – neurological symptomatology – intravenous immunoglobulins – neurological consequences

Sources

1. Yang B, Lian Y, Liu Y et al. A retrospective analysis of possible triggers of Guillain-Barre syndrome. J Neuroimmunol 2016; 293: 17–21. doi: 10.1016/j.jneuroim.2016.02.003.

2. Pacheco LD, Saad AF, Hankins GD et al. Guillain-Barré syndrome in pregnancy. Obstet Gynecol 2016; 128 (5): 1105–1110. doi: 10.1097/AOG.0000000000001716.

3. Vlčková E, Voháňka S, Rajdová A et al. Neuromuskulární choroby a gravidita. Cesk Slov Neurol N 2019; 82/115 (3): 252–264. doi: 10.14735/amcsnn2019252.

4. Hukuimwe M, Masta TT, Gidiri MF. Guillain-Barré syndrome in pregnancy: a case report. Womens Health (Lond) 2017; 13 (1): 10–13. doi: 10.1177/1745505717704128.

5. Chan LY, Tsui MH, Leung TN. Guillain-Barré syndrome in pregnancy. Acta Obstet Gynecol Scand 2004; 83 (4): 319–325.

6. Voháňka S, Štourač P, Klincová M. Anestezie a nervosvalová onemocnění. Cesk Slov Neurol N 2018; 81/114 (5): 501–514. doi: 10.14735/amcsnn2018501.

7. Toscano G, Palmerini F, Ravaglia S et al. Guillain-Barré syndrome associated with SARS-CoV-2. N Engl J Med 2020; 382 (26): 2574–2576. doi: 10.1056/NEJMc2009191.

8. Smith JL. Campylobacter jejuni infection during pregnancy: long-term consequences of associated bacteremia, Guillain-Barré syndrome, and reactive arthritist. J Food Prot 2002; 65 (4): 696–708. doi: 10.4315/0362-028x-65.4. 696.

9. Liu S, Dong C, Ubogu EE. Immunotherapy of Guillain-Barré syndrome. Hum Vaccin Immunother 2018; 14 (11): 2568–2579. doi: 10.1080/21645515.2018.1493415.

10. Škorňa M, Bednařík J, Junkerová J et al. Český národní registr Guillainova-Barého syndromu. Cesk Slov Neurol N 2017; 80/113 (4): 418–427. doi: 10.14735/amcsnn2017 418.

11. Feldman JM. Cardiac arrest after succinylcholine administration in a pregnant patient recovered from Guillain-Barré syndrome. Anesthesiology 1990; 72 (5): 942–944. doi: 10.1097/00000542-199005000-00026.

12. Kalita J, Ranjan A, Misra UK. Outcome of Guillain-Barré syndrome patients with respiratory paralysis. QJM 2016; 109 (5): 319–323. doi: 10.1093/qjmed/hcv190.

13. Luijckx GJ, Vles J, de Beats M et al. Guillain-Barré synrome in mother and newborn child. Lancet 1997; 349 (9044): 27. doi: 10.1016/s0140-67 36 (97) 24001-8.